| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240570 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 10 Pages |
Abstract
When radiation therapy is combined with VEGFR2 and EGFR blockade, significant enhancement of antiangiogenic, antivascular, and antitumor effects are seen in an orthotopic model of lung cancer. These data provide support for clinical trials of biologically targeted and conventional therapies for human lung cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Keiko M.D., Ritsuko M.D., Tomoaki D.D.S., Ph.D., Satoshi M.D., Anderson Ph.D., Juliane M. Ph.D., Luka M.D., Ph.D., Kian M.D., Ph.D., Roy S. M.D., Ph.D., Michael S. M.D.,